Abcellera Total Assets from 2010 to 2024
| ABCL Stock | USD 3.91 0.01 0.26% |
Total Assets | First Reported 2010-12-31 | Previous Quarter 1.5 B | Current Value 989.6 M | Quarterly Volatility 624.2 M |
Check Abcellera BiologicsInc financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Abcellera main balance sheet or income statement drivers, such as Net Interest Income of 44.4 M, Interest Income of 44.4 M or Depreciation And Amortization of 20.4 M, as well as many exotic indicators such as Price To Sales Ratio of 41.25, Dividend Yield of 0.0 or PTB Ratio of 1.36. Abcellera financial statements analysis is a perfect complement when working with Abcellera BiologicsInc Valuation or Volatility modules.
Abcellera | Total Assets |
Latest Abcellera BiologicsInc's Total Assets Growth Pattern
Below is the plot of the Total Assets of Abcellera BiologicsInc over the last few years. Total assets refers to the total amount of Abcellera BiologicsInc assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Abcellera BiologicsInc books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Abcellera BiologicsInc's Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Abcellera BiologicsInc's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 1.49 B | 10 Years Trend |
|
Total Assets |
| Timeline |
Abcellera Total Assets Regression Statistics
| Arithmetic Mean | 437,311,519 | |
| Geometric Mean | 83,685,577 | |
| Coefficient Of Variation | 142.73 | |
| Mean Deviation | 554,159,673 | |
| Median | 21,492,175 | |
| Standard Deviation | 624,158,797 | |
| Sample Variance | 389574.2T | |
| Range | 1.5B | |
| R-Value | 0.80 | |
| Mean Square Error | 150082.5T | |
| R-Squared | 0.64 | |
| Significance | 0.0003 | |
| Slope | 111,850,766 | |
| Total Sum of Squares | 5454038.9T |
Abcellera Total Assets History
Other Fundumenentals of Abcellera BiologicsInc
Abcellera BiologicsInc Total Assets component correlations
Click cells to compare fundamentals
About Abcellera BiologicsInc Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Abcellera BiologicsInc income statement, its balance sheet, and the statement of cash flows. Abcellera BiologicsInc investors use historical funamental indicators, such as Abcellera BiologicsInc's Total Assets, to determine how well the company is positioned to perform in the future. Although Abcellera BiologicsInc investors may use each financial statement separately, they are all related. The changes in Abcellera BiologicsInc's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Abcellera BiologicsInc's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Abcellera BiologicsInc Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Abcellera BiologicsInc. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Total Assets | 1.5 B | 989.6 M | |
| Intangibles To Total Assets | 0.11 | 0.14 |
Abcellera BiologicsInc Investors Sentiment
The influence of Abcellera BiologicsInc's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Abcellera. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Abcellera BiologicsInc's public news can be used to forecast risks associated with an investment in Abcellera. The trend in average sentiment can be used to explain how an investor holding Abcellera can time the market purely based on public headlines and social activities around Abcellera BiologicsInc. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Abcellera BiologicsInc's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Abcellera BiologicsInc's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Abcellera BiologicsInc's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Abcellera BiologicsInc.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Abcellera BiologicsInc in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Abcellera BiologicsInc's short interest history, or implied volatility extrapolated from Abcellera BiologicsInc options trading.
Pair Trading with Abcellera BiologicsInc
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Abcellera BiologicsInc position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abcellera BiologicsInc will appreciate offsetting losses from the drop in the long position's value.Moving together with Abcellera Stock
| 0.71 | JNJ | Johnson Johnson Financial Report 18th of July 2024 | PairCorr |
Moving against Abcellera Stock
| 0.77 | NUVB | Nuvation Bio Financial Report 2nd of May 2024 | PairCorr |
| 0.45 | IOVA | Iovance Biotherapeutics Financial Report 14th of May 2024 | PairCorr |
| 0.41 | IMMP | Immutep Ltd ADR | PairCorr |
The ability to find closely correlated positions to Abcellera BiologicsInc could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Abcellera BiologicsInc when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Abcellera BiologicsInc - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Abcellera BiologicsInc to buy it.
The correlation of Abcellera BiologicsInc is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Abcellera BiologicsInc moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Abcellera BiologicsInc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Abcellera BiologicsInc can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Abcellera BiologicsInc Correlation against competitors. For more information on how to buy Abcellera Stock please use our How to buy in Abcellera Stock guide.Note that the Abcellera BiologicsInc information on this page should be used as a complementary analysis to other Abcellera BiologicsInc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Complementary Tools for Abcellera Stock analysis
When running Abcellera BiologicsInc's price analysis, check to measure Abcellera BiologicsInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abcellera BiologicsInc is operating at the current time. Most of Abcellera BiologicsInc's value examination focuses on studying past and present price action to predict the probability of Abcellera BiologicsInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abcellera BiologicsInc's price. Additionally, you may evaluate how the addition of Abcellera BiologicsInc to your portfolios can decrease your overall portfolio volatility.
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |
Is Abcellera BiologicsInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Abcellera BiologicsInc. If investors know Abcellera will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Abcellera BiologicsInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.459 | Earnings Share (0.51) | Revenue Per Share 0.131 | Quarterly Revenue Growth (0.57) | Return On Assets (0.1) |
The market value of Abcellera BiologicsInc is measured differently than its book value, which is the value of Abcellera that is recorded on the company's balance sheet. Investors also form their own opinion of Abcellera BiologicsInc's value that differs from its market value or its book value, called intrinsic value, which is Abcellera BiologicsInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Abcellera BiologicsInc's market value can be influenced by many factors that don't directly affect Abcellera BiologicsInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Abcellera BiologicsInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Abcellera BiologicsInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Abcellera BiologicsInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.